Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Lenzilumab |
Trade Name | |
Synonyms | KB003|KB 003 |
Drug Descriptions |
Lenzilumab (KB003) is an antibody that targets granulocyte macrophage colony-stimulating factor (GM-CSF), potentially resulting in increased apoptosis and decreased proliferation of tumor cells (PMID: 32294158). |
DrugClasses | |
CAS Registry Number | 1229575-09-0 |
NCIT ID | C125081 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
axicabtagene ciloleucel + Lenzilumab | Lenzilumab axicabtagene ciloleucel | 0 | 1 |
Lenzilumab | Lenzilumab | 0 | 0 |